The Role of Growth Factors in Breast Cancer Prognosis
Author Information
Author(s): P.A. Murray, P. Barrett-Lee, M. Travers, Y. Luqmani, T. Powles, R.C. Coombes
Primary Institution: St Georges Hospital, London and The Royal Marsden Hospital, Sutton, Surrey, UK
Hypothesis
Can the expression levels of transforming growth factors and EGFR predict relapse and survival in breast cancer patients?
Conclusion
High levels of TGF-beta1 are associated with a longer disease-free interval, but overall relapse-free survival was not significantly increased.
Supporting Evidence
- TGF-beta1 expression was inversely correlated with node status.
- Patients with high TGF-beta1 levels had a longer disease-free interval.
- EGFR expression was inversely correlated with ER status.
Takeaway
This study looked at how certain growth factors in breast cancer might help predict how long patients stay healthy after treatment. It found that one factor, TGF-beta1, might be helpful for understanding patient outcomes.
Methodology
The study analyzed mRNA expression of TGF-alpha, TGF-beta1, and EGFR in breast cancer samples and correlated these with clinical outcomes over a median follow-up of 60 months.
Limitations
The study's findings may be limited by the retrospective nature and the potential for confounding factors not accounted for.
Participant Demographics
Patients aged between 36 and 90 years, with a mean age of 62.
Statistical Information
P-Value
0.065
Statistical Significance
p=0.065
Want to read the original?
Access the complete publication on the publisher's website